Seeking Novel Druggable Targets and Drug Screening Systems in Chronic Pain

Asahi Kasei Pharma, a global pharmaceutical company, is seeking novel drug molecules and novel druggable targets in the treatment of chronic pain, as well as in vitro screening systems to identify novel targets for chronic pain. The team is interested in new compounds and targets that will provide therapeutic benefit in the following indications: neuropathic pain, nociceptive pain, nociplastic pain, cancer pain, postoperative pain and other intractable chronic pains.

Approaches of interest:

• Asahi Kasei Pharma is open to different modalities including small...